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Synopsis 
 
Maternal hypertensive disorders are the only distinguishable clinical features 
between growth restricted and non-IUGR stillbirths. 
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Abstract 
 
Objective: Growth restriction is associated with increased risk of stillbirth. Our purpose 
was to compare the autopsy and placental histopathological examination results of 
intrauterine growth retardation (IUGR) and non-IUGR fetal deaths.  
Study Design: Postmortem examination and obstetric risk of stillbirths from 1996 to 
2012 were reviewed retrospectively at the Department of Obstetrics and Gynecology, 
University of Szeged. Forty-seven percent of the 153 stillbirths out of the 34,673 births 
were registered as IUGR.  
Results: Umbilical cord anomaly as an underlying cause of death was significantly less 
prevalent among IUGR stillbirths and predominantly occurred in the late pregnancy. 
Oligohydramnios (p<0.001) and maternal hypertensive diseases (<0.05) were associated 
with greater risk of IUGR among stillbirths. Placental insufficiency was more 
associated to preeclampsia (p<0.05) and maternal hypertensive diseases (p<0.001) 
among IUGR-group than in the non-IUGR group. Any degree of placental degeneration 
was not a distinguishable factor for growth retardation.  
Conclusion: A more intensive surveillance of IUGR and high-risk pregnancies could 
lead to an improvement in stillbirth rate, however, the prevention strategies of IUGR 
stillbirths remains questionable because of very prematurity. 
Keywords: autopsy; placental histology; stillbirth; intrauterine growth retardation; 
obstetric risk  
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Introduction 
 
The intrauterine growth retardation (IUGR) is a condition that affects 5-10% of 
all pregnancies1 and is associated for a significant proportion of stillbirth.2 The IUGR 
fetus is not able to reach its full growth potential, usually because of underlying 
placental pathology.3,4 Recognition of growth restriction is still a challenge despite of 
widely use of ultrasound examinations and a higher detection of IUGR cases would be 
necessary by the elaboration of new clinical protocols (fetal kick charts, fundal height 
measurements, serial ultrasound examinations) in order to decrease stillbirth rates.3 
It is known that there is an increase in the risk of stillbirth in IUGR fetuses 
compared to non-IUGR fetuses at all gestational ages.5 It is supposed that the 
predominant cause of death in IUGR is the severe placental insufficiency leading to 
multiorgan failure and cardiovascular collapse.6,7 However, the differences in risk 
factors and causes of intrauterine death (IUFD) between IUGR and non-IUGR stillbirths 
have not received much attention yet. 
Our aim, therefore, was to evaluate, the differences in the risk factors, autopsy 
and placental histopathological results between the intrauterine fetal deaths (IUFDs) 
with IUGR and without growth restriction. 
 
Material and Methods 
 
The placental histopathology and fetal autopsy findings concerning all stillbirths 
occurred at the Department of Obstetrics and Gynecology, University of Szeged, 
Hungary from January 1996 to April 2012 were reviewed. Stillbirth was defined as fetal 
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death prior to delivery. According to the Hungarian regulations,8 only stillbirths with 
weight ≥500 g and/or ≥24 gestational weeks were selected . Gestational age was 
determined using an algorithm combining last menstrual period and early ultrasound 
data. The clinical data were collected from the databases of the Department of 
Obstetrics and Gynecology, University of Szeged. Autopsies and placental 
histopathological examinations performed by the pathologists proved the cause of fetal 
death in most of the cases, but the clinical course was also considered.9 Subsequently, 
the cause of stillbirth was determined by a consensus between the gynecologists on the 
basis of relevant clinical findings and the pathologists reporting the autopsy and 
placental histopathological results. Intrauterine growth retardation (IUGR) was 
determined as fetal weight below the 10th percentile, using the Hungarian birth weight 
centiles. Placental insufficiency was defined as inadequate spiral artery remodeling 
and/or spiral artery pathology leading to an uteroplacental vascular insufficiency, such 
as 1) acute placental infarction (>20%) and/or 2) calcification (>20%), or 3) a placental 
hematoma with intervillous thrombosis. The placental insufficiency group comprised 
also morphologic abnormalities that arise because of abnormal developmental processes 
and acquired placenta parenchyma disorders of the villi/intervillous space (>20%) (as 
classified at the Department of Pathology, University of Szeged). Placental lesions were 
also recorded by the pathologists, even when these histopathological observations did 
not reach a level of 25% and were not so severe as to cause stillbirth.10 Infectious cause 
of death was defined as an autopsy with evidence of organ involvement with an 
organism and/or histological placental examination with infectious findings.11 Umbilical 
cord occlusion was diagnosed as a cause of death when a constricting knot/loop around 
the neck could be recognized with a histopathological evidence of chronic fetal vascular 
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obstruction.12 The body mass index (BMI) was considered as the body weight (kg) per 
height (m2) at delivery. Hypertensive disorders were defined as presence of 
preeclampsia or pregnancy induced hypertension or essential hypertension. 
Comparison between variables was constructed by binary logistic regression to 
evaluate the effect of the fetal and placental weight and ratio on various study factors 
adjusted for gestational age (GA) at stillbirth to eliminate the confounding effect of GA. 
Logistic regression coefficient values and equations depending on GA were also 
calculated when the effect of the study factor was significant on the fetal growth. The 
Mantel-Haenszel test was applied to compare frequency of placental insufficiency 
between IUGR and non-IUGR groups in relation to other factors. Analyses were 
performed using SPSS 17.0 (SPSS Statistics, Chicago, IL, USA). A p value of <0.05 
was required to reject the null hypothesis. 
 
Results 
 
From January 1996 to December 2013, 144 singleton stillbirths out of 36,447 
births were registered at the Department of Obstetrics and Gynecology, University of 
Szeged, demonstrating a stillbirth rate of 3.95‰. 
Clinical details concerning IUGR stillbirths and non-IUGR stillbirths are 
presented in Table 1. Among 144 stillbirths, 67 (46.53%) had the birth weight below the 
10th percentile, whereas 77 (53.47%) were non-IUGR. There was no significant 
difference in regards of age between the mothers of stillbirths with IUGR and those 
with non-IUGR. Surprisingly, inadequate pregnancy care was more common both in the 
non-IUGR-group (15.2%) and in the IUGR-group (3.4%). Mothers with IUGR stillbirth 
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had slightly lower BMI than those with non-IUGR stillbirth, although the difference 
was not significant. Interestingly, the rate of smokers was considerably higher among 
mothers with pregnancies affected by IUGR as compared to non-IUGR pregnancies, but 
the difference was not significant. The grade of tobacco use did not differ in the birth 
weight groups. 
As regards the gestational age at delivery, mothers of stillbirths born with a low 
birth weight had a minimally shorter pregnancy (30.81±3.60 weeks) than their 
counterparts with appropriate weight for gestational age (31.77±4.50 weeks). Only 
small proportions of mothers had previous unfavourable obstetric outcome and the 
frequency in-vitro fertilization precedent pregnancy was also notably low in both study 
groups. 
Oligohydramnios (23.9% vs. 1.3%, p < 0.001) and hypertensive disorders 
(32.9% vs. 10.4%, p < 0.05) were significantly more frequent among the IUGR-
pregnancies. Furthermore, preeclampsia alone was also significantly more prevalent 
among IUGR (23.9%) than non-IUGR cases (5.2%, p = 0.003). The incidences of 
diabetes mellitus and gestational diabetes mellitus were lower in the IUGR group (1.5% 
vs. 2.6% and 3.0% vs.9.2%, respectively), without significant differences. Placental 
weight was almost doubled in the non-IUGR group as compared to those in the IUGR-
group (Table 2). 
IUGR was not associated significantly with placental insufficiency (29.9% vs. 
26.0%), even though there was a significant difference in any grade of the placental 
degenerations among IUGR and non-IUGR pregnancies (68.7% vs 48.1%, p=0.018). 
The incidence of the umbilical cord pathology was not significantly different in the two 
study groups (11.9% vs. 20.8%). Furthermore, there was no significant difference in the 
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occurrences of other causes or unexplained cases between the IUGR and non-IUGR 
pregnancies. No case of intrapartum fetal death was recorded (Table 3). 
Significantly more cases with placental insufficiency had preeclampsia relative 
to the cases with no placental insufficiency in the IUGR group (OR: 1:37) than did have 
those in the non-IUGR group (OR: 0.95). This relationship was more pronounced in 
hypertensive disorders among the patients with IUGR than those who had no IUGR 
(Table 4). 
 
Discussion 
 
Intrauterine growth restriction (IUGR) remains one of the main challenges in 
maternity care and about half of the stillbirths are growth restricted. To our knowledge 
this is the first study demonstrating the comparison of the background of the IUGR and 
non-IUGR stillbirths. In our study, a slightly higher frequency of fetal growth restriction 
was observed among stillbirths (47%) than that found in other studies (35%-43%).13-15 
It is well known that IUGR is often related to sonographically detected placenta 
insufficiency.6,16 However, one of our major results is that a histologically verified 
placental insufficiency is not dominating among IUGR-stillbirths. Surprisingly, a 
substantial proportion of the non-IUGR stillbirths also exhibit insufficiency 
background, which could be explained by several issues. Population charts were applied 
in our study in order to detect restricted fetal growth which could be inferior to 
customized growth charts.2,3,17 Furthermore, the comparable placental insufficiency 
rates in the two study groups could be explained by the fact that a considerable 
proportion of the non-IUGR fetuses might restricted customized growth potential. In 
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addition, the rate of IUGR among stillbirths could be influenced by the clinical 
management of the high-risk pregnancies. 
It is documented that the placental surface area is the principal determinant of 
adequate fetal oxygenation18,19 and it is a cornerstone that the fetal birthweight is 
directly correlated with placental weight.20 This is confirmed in our study among 
stillbirths, even though the placental insufficiency/any degree of placental degeneration 
is not significantly more prevalent in the IUGR group compared to non-IUGR 
counterparts. This paradoxon could be explained by the fact that decreased placental 
weight is more linked to restricted growth than histologically demonstrable lesions,21 
but further research is required for clarification. 
In our analysis, oligohydramnios and preaeclamspia are strongly correlated with 
IUGR stillbirths, which is in accordance with studies on live births.22,23 According to 
Salafia et al.,18 placental insufficiency is not associated with preeclampsia neither in the 
IUGR nor in the non-IUGR group. However if IUGR goes together with preeclampsia 
the risk of placental insufficiency is significantly elevated compared to cases with non-
IUGR accompanied with preeclampsia, and this was more so in case of all hypertensive 
diseases. This can be explained with the observation of Egborn,24 who confirmed the 
association between abnormal placental morphology in early-onset preeclampsia. In our 
stillbirth population, the majority of cases were with early-onset type preeclampsia.  
The prevalence of the abnormality of the umbilical cord is 16.3% in our study 
group, however, the literature data show wide range of 5.2%-42%.13,25,26 To our 
knowledge, there has not been any report focusing on umbilical cord pathology in 
stillbirths with growth retardation. One of our most striking results is that fatal 
compromise of umbilical circulation contributes a significantly less stillbirth among 
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IUGR pregnancies than among those with normal birth weight. As in other reports,25 the 
fatal compromise of umbilical circulation occurs mostly in the third trimester, whereas 
the stillbirths in the IUGR-group occur mostly in the earlier period of the pregnancy. 
Another possible explanation could be that the small fetuses exhibit a movement pattern 
with lower intensity and amplitude.27 Our data suggest that the stillbirth caused by 
umbilical cord abnormalities is predisposed in an unselected pregnancy population and 
the fatal episode might happen accidentally (68% had no obstetric risk), whereas the 
high risk pregnancies associated with IUGR are examined and screened more 
intensively, leading to a decrease in cord complication.  
Unfortunately, the options of intrauterine treatment of IUGR foetuses are very 
limited. Thus, in most cases, the obstetric management has to aim on surveillance of 
foetal health and on finding the optimal time of delivery. Generally, to avoid stillbirth, 
the IUGR foetuses have to be delivered extremely preterm and then the obstetrician 
faces the task of balancing the risk of intrauterine asphyxia eventually resulting in 
stillbirth against the risks of extremely early prematurity (25.0% in our dataset). IUGR 
is often related with the malfunctioning placenta and is asymptomatic. The detection of 
IUGR fetuses necessitates a screening of the whole pregnant population with Doppler 
ultrasound and biometry or only target populations (e.g., pregnancies with declining 
symphysis–fundal height or high-risk pregnancies). If the IUGR is related to a maternal 
disorder (i.e. pre-eclampsia or maternal hypertension), then obstetric management could 
theoretically prevent stillbirths. In our population, all of IUGR-stillbirths had at least 
one obstetric risk which could adjust stillbirth, whereas the corresponding data was 
45.7% for non-IUGR pregnancies, although 30 mothers (19.6%) had not attended 
regular prenatal care schedules. Another major challenge is the surveillance of those 
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fetuses apparently with a weight over 10th percentile, but with a decreasing growth 
potential, which is unknown in our population.  
The biometric evaluation of foetal growth is mainly useful in identifying SGA 
foetuses; for timing of delivery, methods evaluating foetal physiological functions, for 
example, Doppler examination of foetal and placental haemodynamics, have a higher 
predictive value. Still, the degree of foetal ‘smallness’ should be taken in account when 
making decisions on obstetric management of IUGR foetuses. 
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Table 1. Baseline characteristics of the mothers affected by stillbirth born with 
intrauterine growth retardation (IUGR) stillbirths (n=67) and those with non-IUGR 
stillbirths (n=77) at the Department of Obstetrics and Gynaecology, University of 
Szeged, Hungary between January 1st, 1996 and December 31st, 2012.* 
 IUGR (n=67) Non-IUGR (n=77) p 
value 
AOR 
(95% CI)** n % n % 
Age (years±S.D.) 
28.52±5.58 28.94±6.48 0.60 
0.99 (0.93-
1.04) 
Advanced age (>35 
years) 
9 13.4 14 18.2 0.35 
0.64 (0.26-
1.62) 
Inadequate 
pregnancy care 
2 3.4 10 15.2 0.07 
0.23 (0.05-
1.11) 
Body mass index 
(kg/m2) 
26.39±4.31 28.13±5.41 0.075 
0.94 (0.87-
1.01) 
Smoking 13 19.7 10 13.0 0.20 
1.82 (0.73-
4.54) 
   Heavy smoking 
(>10 cigarettes/day) 
4 6.1 4 5.2 0.72 
1.30 (0.31-
5.49) 
   Light smoking 
(≤10 cigarettes/day) 
9 13.6 6 6.8 0.21 
2.02 (0.67-
6.11) 
* Binary logistic regression adjusted for gestational age. 
** Adjusted odds ratio, 95% confidence interval
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Table 2. Obstetric characteristics of the mothers affected by stillbirth born with 
intrauterine growth retardation (IUGR) (n=67) and those with non-IUGR stillbirths 
(n=77) at the Department of Obstetrics and Gynaecology, University of Szeged, Hungary 
between January 1st, 1996 and December 31st, 2012.* 
 IUGR (n=67) Non-IUGR (n=77) p 
valu
e 
AOR 
(95% CI)** 
n % n % 
Gestational age 
(weeks±S.D.) 
30.81±3.60 31.77±4.50 0.23  
Previous pregnancy 
loss 
2 3.0 5 6.5 0.33 
0.43 (0.08-
2.32) 
Previous stillbirth 4 6.0 3 3.9 0.61 
1.50 (0.32-
7.03) 
Pregnancy after in-
vitro fertilization 
0 0.0 1 1.3 1.00 
0.01 (0.01-
0.01) 
Preeclampsia 16 23.9 4 5.2 
0.00
3 
5.98 (1.87-
19.07) 
Pregnancy induced 
hypertension 
3 4.5 4 5.2 0.92 
0.92 (0.20-
4.33) 
Essential 
hypertension 
3 4.5 3 3.9 0.86 
1.16 (0.22-
6.04) 
Oligohydramnios 16 23.9 1 1.3 
0.00
3 
22.39 (2.86-
175.42) 
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Any type of 
diabetes mellitus 
3 4.5 9 11.8 0.11 
0.34 (0.09-
1.31) 
Placental weight 258.0±128.18 391.0±162,0 
<0.0
01 
0.99 (0.98-
0.99) 
* Binary logistic regression adjusted for gestational age. 
** Adjusted odds ratio, 95% confidence interval
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Table 3. Categories of the causes of death of stillbirths by the mothers with IUGR stillbirths 
(n=67) and non-IUGR stillbirths (n=77) at the Department of Obstetrics and Gynaecology, 
University of Szeged, Hungary between January 1st, 1996 and December 31st, 2012.* 
 IUGR (n=67) Non-IUGR (n=77) p 
value 
AOR 
(95% CI) ** n % n % 
Placental 
insufficiency 
20 29.9 20 26.0 0.58 
1.23 (0.59-
2.57) 
Umbilical cord 
pathology 
8 11.9 16 20.8 0.18 
0.53 (0.21-
1.33) 
Unexplained 34 43.3 29 37.7 0.51 
1.25 (0.64-
2.46) 
Other 10 14.9 12 15.6 0.87 
0.92 (0.37-
2.31) 
* Binary logistic regression adjusted for gestational age. 
** Adjusted odds ratio, 95% confidence interval  
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Table 4. Mantel-Haenszel test on placental insufficiency as cause  
 IUGR (N=67) 
OR** 
Non-IUGR (N=77) 
OR** 
p-
value 
Placental 
insufficiency 
(n=20) 
No placental 
insufficiency 
(n=47) 
Placental 
insufficiency 
(n=20) 
No placental 
insufficiency 
(n=57) 
n % n % n % n % 
Preeclampsia 4 20.0 12 25.5 1.37 1 5.0 3 5.3 0.95 <0.05 
Hypertensive 
disorders* 
6 30.0 15 31.9 1.09 1 5.0 9 15.8 0.28 <0.05 
* All type of hypertensive disorders during pregnancy 
** OR: odds ratio 
 
 
